# Bioceptive

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioceptive

- Industry: Medical Devices & Equipment
- Headquarters: New Orleans, US
- Website: www.bioceptive.com
- Total disclosed funding: $0.2M
- Latest round: Seed (Mar 26, 2012)
- Investors on record: 3

## About

Bioceptive is a medical device company focused on enhancing women's healthcare through innovative solutions. Their flagship products include FDA-approved devices designed to improve gynecological procedures and patient comfort.Founded in 2010 and based in New Orleans, US, Bioceptive develops specialized medical devices for women's health. The company has undergone strategic shifts and has executed five deals, including a funding round in January 2016 where they raised USD 0.416 million. The CEO is Vicki Briggs, and the founder is Ben Cappiello.Bioceptive specializes in the development of innovative medical devices aimed at improving women's healthcare. Their core products include the patented Cervical Suction Retractor (CSR) and an advanced IUD inserter, both of which are FDA-approved. The CSR serves as a gentle alternative to the traditional tenaculum used during gynecological procedures, minimizing discomfort and enhancing the patient experience. The IUD inserter is designed to facilitate IUD insertions, allowing advanced practice providers to expand access to these essential services. Bioceptive's products are aimed at healthcare professionals working in women's health and are primarily marketed in North America, including the United States and Canada. The company’s focus on safety, efficiency, and patient comfort addresses critical needs in gynecological procedures, thereby contributing to improved health outcomes for women.Bioceptive generates revenue through direct sales of its medical devices to healthcare providers and institutions. The company’s flagship products, including the Cervical Suction Retractor and the IUD inserter, are sold directly to clinics and hospitals, enhancing the distribution networks for women's healthcare solutions. Bioceptive’s transaction structure is primarily B2B, establishing partnerships with healthcare facilities that require modern, effective medical devices. Given the commitment to accessibility, these products are priced to ensure affordability for healthcare providers while maintaining product quality. The revenue model is underpinned by a focus on providing innovative solutions that meet the evolving needs of the women's health sector, thereby fostering long-term client relationships and expanding market reach.Looking ahead, Bioceptive plans to innovate further with new products aimed at enhancing women's healthcare, although specific release dates are not disclosed. The company is targeting expansion into new geographic markets beyond North America, with plans to establish a presence in Europe and Asia by 2025. The recent funding raised in January 2016, amounting to USD 0.416 million, will support these initiatives, primarily focusing on product development and market entry strategies.

## Funding rounds

- Seed, Mar 26, 2012, $0M — Gray Ghost Ventures, Abstraction Ventures
- Seed, Aug 15, 2011, $0.1M — Village Capital

## Investors

- Village Capital (https://capitalatlas.ai/funds/village-capital) — Seed
- Gray Ghost Ventures (https://capitalatlas.ai/funds/gray-ghost-ventures) — Seed
- Abstraction Ventures (https://capitalatlas.ai/funds/abstraction-ventures) — Seed